Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nippon Soda, Oct-Dec (3Q) Ordinary Profit Increases by 3%
4041 Nippon Soda Co.,Ltd. 【J-GAAP】
Earnings ReportNippon Soda Co.,Ltd. <4041> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 4.7% from the same period last year to 14.5 billion yen. However, the progress rate toward the full-year plan of 17.7 billion yen was 82.3%, also surpassing the five-year average of 55.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to significant drop 60.8% from the same period last year to 3.13 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 3.4% from the same period last year, reaching 6.19 billion yen. The operating profit margin improved from 9.1% in the same period last year to 10.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 124,253 | 14,781 | 20,849 | 13,275 | 238.1 | 78.8 | Feb 3, 2023 | J-GAAP |
Apr - Dec, 2023 | 105,355 | 9,774 | 15,286 | 11,784 | 211.5 | 65.6 | Feb 9, 2024 | J-GAAP |
Apr - Dec, 2024 | 107,304 | 11,198 | 14,563 | 12,538 | 227.7 | 82.3 | Feb 13, 2025 | J-GAAP |
YoY | +1.8% | +14.6% | -4.7% | +6.4% | +7.7% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 85,527 | 7,414 | 14,005 | 9,072 | 163.1 | 60 | May 14, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 85,921 | 6,423 | 9,336 | 6,254 | 113.5 | 60 | Nov 13, 2024 | J-GAAP |
YoY | +0.5% | -13.4% | -33.3% | -31.1% | -30.4% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 172,811 | 16,893 | 26,456 | 16,692 | 299.4 | 120 | May 10, 2023 | J-GAAP |
Mar, 2024 | 154,429 | 13,872 | 23,297 | 16,612 | 298.7 | 120 | May 14, 2024 | J-GAAP |
Mar, 2025 Guidance | 153,000 | 13,500 | 17,700 | 12,600 | 228.8 | 120 | Nov 13, 2024 | J-GAAP |
YoY | -0.9% | -2.7% | -24.0% | -24.2% | -23.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 36,453 | 3,316 | 5,994 | 4,244 | 76.2 | 9.1 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 49,074 | 4,098 | 8,011 | 4,828 | 86.8 | 8.4 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 32,195 | 3,069 | 5,233 | 4,337 | 78.8 | 9.5 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 34,884 | 4,008 | 3,131 | 2,009 | 36.5 | 11.5 | Nov 13, 2024 | J-GAAP |
Oct - Dec, 2024 | 40,225 | 4,121 | 6,199 | 6,192 | 112.4 | 10.2 | Feb 13, 2025 | J-GAAP |
YoY | +10.3% | +24.3% | +3.4% | +45.9% | +47.6% |
Related Articles
CREATE MEDIC, 39% Increase in Ordinary Profit for The Current Fiscal Year
Disruptors, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.6 times, Oct-Dec Ordinary Profit Turns to Profit
TAIKO PHARMA, 71% Decrease in Ordinary Profit for The Current Fiscal Year
Vertex, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 9%
IFIS JAPAN, 14% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
EBRAINS, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 16%
GOURMET KINEYA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.4 times, Exceeds Full-Year Plan
LAND BUSINESS, Oct-Dec (1Q) Net Income Turns to Loss
Mitsubishi Materials, The Current Fiscal Year Ordinary Profit Revised Downward by 6%
Voltage Inc, First Half Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Turns to Profit